HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer is a research paper published in Molecular Imaging and Biology (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
RSNA Research and Education Foundation
Grant: Research Resident Grant
Massachusetts General Hospital
Grant: Ralph Schlaeger Research Fellowship Grant
NIH
Grant: R01CA211223
NIH
Grant: NCI K08CA249047-01
NIH
Grant: 5R25CA174650
NIH
Grant: S10-OD023503
National Institutes of Health
Grant: 1S10OD023503-01
MRI-Compatible PET Insert for Small Bore Scanner
National Institutes of Health
Grant: 5K08CA249047-03
Enhancing the therapeutic effect of receptor radionuclide therapy in neuroendocrine tumors by somatostatin receptor upregulation
National Institutes of Health
Grant: 5R21GM137227-02
A Proof-of-concept of Vitamin B3 for Metabolic MR Imaging
National Institutes of Health
Grant: 5K08CA259626-04
Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma
National Institutes of Health
Grant: 2R25CA174650-06
CaNCURE: Cancer Nanomedicine Co-ops for Undergraduate Research Experiences
National Institutes of Health
Grant: 5R01CA211223-02
Quantitative HER3 PET Imaging for Assessing Resistance and Guiding Therapy
FWCI
0.28
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals